Cedar Mountain Advisors’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Cedar Mountain Advisors’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,501	Closed	-$2.25K	–	364
2024 Q2	$2.25K	Hold	2,501	–	–	﹤0.01%	268
2024 Q1	$3.7K	Hold	2,501	–	–	﹤0.01%	246
2023 Q4	$2.88K	Hold	2,501	–	–	﹤0.01%	245
2023 Q3	$5.35K	Buy	+2,501	New	+$6.04K	﹤0.01%	208
2023 Q2	–	Sell	-2,500	Closed	-$6.97K	–	313
2023 Q1	$6.97K	Hold	2,500	–	–	﹤0.01%	188
2022 Q4	$6.72K	Hold	2,500	–	–	﹤0.01%	185
2022 Q3	$12K	Hold	2,500	–	–	﹤0.01%	149
2022 Q2	$27K	Buy	+2,500	New	+$21.8K	0.01%	99
2022 Q1	–	Sell	-2,500	Closed	-$60K	–	351
2021 Q4	$60K	Buy	2,500 +1,667	+200%	+$39.3K	0.02%	71
2021 Q3	$15K	Buy	+833	New	+$15.6K	0.01%	140

Other funds holding BTCY

SFCL

Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PWA

Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Cedar Mountain Advisors's BTCY Position: Q3 2024 in Review

Cedar Mountain Advisors sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 2,501 shares — an estimated $2.25K sold.

Cedar Mountain Advisors first reported a position in BTCY in Q3 2021 and held it in 10 quarters. The position peaked at $60K in Q4 2021. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

Cedar Mountain Advisors reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Cedar Mountain Advisors sold 2,501 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $2.25K.
Cedar Mountain Advisors first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
Cedar Mountain Advisors's Biotricity, Inc. Common Stock position peaked at $60K in Q4 2021.
5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on Cedar Mountain Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.